Volume | 5 |
|
|||||
News | - | ||||||
Day High | 279.05 | Low High |
|||||
Day Low | 279.05 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Bio Rad Laboratories Inc | BIO.B | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
279.05 | 279.05 | 279.05 | 279.91 | 279.91 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
3 | 5 | - | 271.00 - 467.95 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:00:00 | 5 | $ 279.05 | USD |
Bio Rad Laboratories Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
7.98B | 28.52M | - | 2.67B | -637.32M | -22.35 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Bio Rad Laboratories News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BIO.B Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 279.00 | 280.75 | 277.94 | 279.91 | 17 | 0.91 | 0.33% |
1 Month | 350.09 | 350.09 | 275.65 | 317.33 | 100 | -70.18 | -20.05% |
3 Months | 317.30 | 357.67 | 275.65 | 333.87 | 325 | -37.39 | -11.78% |
6 Months | 273.90 | 357.67 | 271.00 | 327.31 | 212 | 6.01 | 2.19% |
1 Year | 464.10 | 467.95 | 271.00 | 338.39 | 131 | -184.19 | -39.69% |
3 Years | 639.56 | 879.00 | 271.00 | 506.00 | 112 | -359.65 | -56.23% |
5 Years | 311.56 | 879.00 | 271.00 | 461.68 | 157 | -31.65 | -10.16% |
Bio Rad Laboratories Description
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier. |